Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

466
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
466
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.4K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
Skin Cancer01:30

Skin Cancer

3.1K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
3.1K
Cancer Vaccines01:30

Cancer Vaccines

330
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
330

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Brief Communication: Personalized Circulating Tumor DNA as a Predictor of Pathologic Response in Neoadjuvant Treatment of Resectable Melanoma.

Journal of immunotherapy (Hagerstown, Md. : 1997)·2026
Same author

Impact of immune checkpoint inhibition on ovarian reserve.

The oncologist·2026
Same author

Longitudinal ctDNA Monitoring for Postsurgical Disease Surveillance in Patients with Stage I to IIIB Melanoma.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same author

Mechanisms of tumor persistence in metastatic melanoma following successful immunotherapy.

bioRxiv : the preprint server for biology·2025
Same author

Advanced stage melanoma during pregnancy: recommendations from a retrospective, multicentre, registry-based study.

EClinicalMedicine·2025
Same author

Phase 1b Study of Tovorafenib, Plozalizumab or Vedolizumab Plus Standard-of-Care Immune Checkpoint Inhibitors in Patients with Advanced Melanoma.

Journal of Cancer·2025

Related Experiment Video

Updated: May 30, 2025

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

3.3K

Individualized Neoantigen-Directed Melanoma Therapy.

Karam Khaddour1,2,3, Elizabeth I Buchbinder4,5,6

  • 1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02115, USA. karam_khaddour@dfci.harvard.edu.

American Journal of Clinical Dermatology
|January 28, 2025
PubMed
Summary

Personalized neoantigen vaccines harness the patient's immune system to target melanoma. This individualized therapy identifies unique tumor neoantigens to create tailored treatments, enhancing efficacy and reducing side effects.

More Related Videos

A 3D Organotypic Melanoma Spheroid Skin Model
08:49

A 3D Organotypic Melanoma Spheroid Skin Model

Published on: May 18, 2018

15.6K
A Melanoma Patient-Derived Xenograft Model
07:07

A Melanoma Patient-Derived Xenograft Model

Published on: May 20, 2019

12.3K

Related Experiment Videos

Last Updated: May 30, 2025

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

3.3K
A 3D Organotypic Melanoma Spheroid Skin Model
08:49

A 3D Organotypic Melanoma Spheroid Skin Model

Published on: May 18, 2018

15.6K
A Melanoma Patient-Derived Xenograft Model
07:07

A Melanoma Patient-Derived Xenograft Model

Published on: May 20, 2019

12.3K

Area of Science:

  • Oncology
  • Immunology
  • Personalized Medicine

Background:

  • Melanoma exhibits significant genetic heterogeneity, necessitating individualized treatment strategies.
  • Current therapies often lack specificity, leading to potential off-target effects.
  • Neoantigen-directed therapy offers a personalized approach by targeting unique tumor mutations.

Purpose of the Study:

  • To review the rationale behind individualized neoantigen-directed therapies for melanoma.
  • To summarize the current advancements in personalized neoantigen vaccines for melanoma treatment.

Main Methods:

  • Identification of patient-specific immunogenic neoantigens (mutated proteins).
  • Development of therapeutic vaccines (peptide or RNA) encoding identified neoantigens.
  • Clinical trials combining neoantigen vaccines with immune checkpoint inhibitors.

Main Results:

  • Neoantigen vaccines aim to induce specific immune responses against cancer cells.
  • Personalized therapy shows potential for reduced side effects and improved efficacy.
  • Clinical trials demonstrate promising outcomes when combining neoantigen vaccines with immune checkpoint inhibitors.

Conclusions:

  • Individualized neoantigen-directed therapy is a promising, tailored approach for melanoma.
  • Further research and clinical trials are essential to optimize this personalized treatment strategy.
  • Neoantigen vaccines represent a significant advancement in the personalized treatment of melanoma.